Product
IV Chemotherapy
1 clinical trial
2 indications
Indication
CancerClinical trial
A Phase 1b, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib Monotherapy and in Combination With Other Anti-cancer Therapies in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)Status: Recruiting, Estimated PCD: 2026-12-20